ICD10 code of Alpha 1-antitrypsin deficiency and ICD9 code

The primary medical billing code for Alpha 1-antitrypsin deficiency is E88.01 under the ICD-10-CM classification system. In the older ICD-9-CM system, this condition was coded as 273.4.

What is Alpha 1-antitrypsin deficiency?

Alpha 1-antitrypsin deficiency is a genetic disorder that occurs when the liver does not produce enough of the alpha-1 antitrypsin (AAT) protein. This protein is essential for protecting the lungs from damage caused by inhaled irritants and enzymes like neutrophil elastase. When levels are insufficient, individuals are at a significantly higher risk for developing early-onset emphysema and, in some cases, chronic liver disease. Because Alpha 1-antitrypsin deficiency is often underdiagnosed, it is crucial for patients and providers to understand its coding and clinical implications.

Why are medical codes for Alpha 1-antitrypsin deficiency important?

Accurate medical coding, such as using ICD-10 code E88.01, is vital for both clinical management and administrative purposes. These codes allow healthcare systems to track the prevalence of Alpha 1-antitrypsin deficiency, facilitate insurance coverage for necessary treatments like augmentation therapy, and ensure that patients are correctly categorized in medical registries. With 339 people with Alpha 1-antitrypsin deficiency already connected through the DiseaseMaps.org community, standardized coding helps ensure that clinical data remains consistent across the global patient population.

How is Alpha 1-antitrypsin deficiency inherited and diagnosed?

Alpha 1-antitrypsin deficiency is an autosomal codominant genetic condition, meaning a child inherits one gene from each parent. The most common severe deficiency is associated with the "ZZ" genotype. Diagnosis is typically confirmed through a combination of blood tests and genetic analysis. Key diagnostic indicators include:

• Serum AAT levels: Measuring the concentration of the protein in the blood.


• Phenotyping/Genotyping: Identifying the specific protease inhibitor (Pi) type, such as PiZZ, PiSZ, or PiMZ.


• Liver function tests: Assessing for potential damage caused by the accumulation of abnormal AAT proteins in the liver.


• Pulmonary function testing: Evaluating the extent of lung impairment or emphysema.

What are the psychological impacts of living with this condition?

Receiving a diagnosis of Alpha 1-antitrypsin deficiency can be overwhelming, particularly because it is a lifelong genetic condition. Patients often experience anxiety regarding lung health, the potential for liver complications, and the necessity of long-term medical monitoring. Our clinical psychologists emphasize that while the diagnosis is serious, understanding the specific ICD-10 coding and management pathways can provide a sense of control and clarity. Connecting with the 339 community members on DiseaseMaps.org can help mitigate the isolation that often accompanies rare disease diagnoses.

Next steps

• Consult a pulmonologist or hepatologist specializing in Alpha 1-antitrypsin deficiency for a personalized care plan.


• Ensure your medical records correctly reflect the E88.01 code to facilitate access to specialized treatments.


• Consider genetic counseling to understand the implications for family members who may also carry the gene.


• Join the Alpha 1-antitrypsin deficiency community on DiseaseMaps.org to share experiences and learn from others living with the condition.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Alpha-1 antitrypsin deficiency (ORPHA:97)


• NIH Genetic and Rare Diseases Information Center (GARD): Alpha-1 antitrypsin deficiency


• OMIM (Online Mendelian Inheritance in Man): Alpha-1-Antitrypsin Deficiency (Entry #613490)


• Alpha-1 Foundation: Clinical resources and patient support guidelines